Fabtech Technologies Presents Investor Presentation for 9M FY26 Results
Fabtech Technologies reported 9M FY26 total income of ₹26,309.11 lakhs, up 32.79% YoY. However, EBITDA decreased 45.04% to ₹2,390.12 lakhs and net profit fell 48.02% to ₹1,630.23 lakhs. The order book stands at ₹98,305 lakhs. The company is focusing on its global turnkey solutions for life sciences and healthcare.
The mixed financial results, with a notable drop in profitability despite revenue growth, and a substantial order book, warrant a medium impact assessment for investors.
While revenue has increased, there is a significant decrease in EBITDA and net profit, indicating mixed financial performance. The presentation is primarily informational.
Fabtech Technologies Limited has submitted an investor presentation detailing the unaudited financial results for the quarter and nine months ended December 31, 2025. The presentation, submitted on February 09, 2026, outlines the company's performance and strategic positioning.
Key financial highlights for the nine months of FY26 (April 2025 - December 2025) show a Total Income of ₹26,309.11 lakhs, an increase of 32.79% compared to the same period in the previous year. However, EBITDA stood at ₹2,390.12 lakhs, a decrease of 45.04% from 9M FY25, with the EBITDA margin declining to 9.08% from 21.95%. Net profit for the period was ₹1,630.23 lakhs, a decrease of 48.02% year-on-year, resulting in a Net Profit Margin of 6.20% and an EPS of ₹4.49, down from ₹9.68 in 9M FY25.
The company's order book as of November 03, 2025, was ₹98,305 lakhs. Fabtech Technologies emphasizes its role as a global turnkey solutions provider to the life sciences and healthcare sectors, with a significant portion of its revenue, 78%, derived from MENA, GCC, and ECO Zone markets. The presentation also details the deployment of issue proceeds, with ₹12,700.00 lakhs allocated for working capital, ₹3,000.00 lakhs for inorganic growth initiatives, and ₹4,927.02 lakhs for general corporate purposes, with ₹52.38 lakhs remaining for estimated issue expenses.
What to do with a filing like this
Fabtech Technologies Limited filed this with the NSE as a statutory disclosure, categorised under investor presentation. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Fabtech Technologies Limited. Read the original for the full detail.